Windlas Biotech Ltd
NSE:WINDLAS
Windlas Biotech Ltd
NSE:WINDLAS
Price:
784.45
INR
-0.29%
Market Closed
Market Cap:
₹16.5B
Cash Flow Statement
Cash Flow Statement
Windlas Biotech Ltd
Windlas Biotech Ltd
Currency: INR
| Mar-2023 | Sep-2023 | Mar-2024 | Sep-2024 | Mar-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||
| Net Income |
570
|
625
|
771
|
810
|
798
|
880
|
|
| Depreciation & Amortization |
124
|
132
|
134
|
196
|
280
|
303
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
25
|
0
|
|
| Other Non-Cash Items |
(45)
|
(44)
|
(64)
|
(68)
|
(89)
|
(80)
|
|
| Cash Taxes Paid |
97
|
111
|
186
|
179
|
209
|
210
|
|
| Cash Interest Paid |
8
|
8
|
11
|
22
|
44
|
49
|
|
| Change in Working Capital |
(40)
|
225
|
248
|
(90)
|
(306)
|
(159)
|
|
| Cash from Operating Activities |
610
N/A
|
938
+54%
|
1 090
+16%
|
849
-22%
|
682
-20%
|
945
+39%
|
|
| Investing Cash Flow | |||||||
| Capital Expenditures |
(709)
|
(753)
|
(377)
|
(532)
|
(522)
|
(505)
|
|
| Other Items |
568
|
13
|
(544)
|
(318)
|
(219)
|
(300)
|
|
| Cash from Investing Activities |
(141)
N/A
|
(741)
-425%
|
(921)
-24%
|
(850)
+8%
|
(741)
+13%
|
(804)
-9%
|
|
| Financing Cash Flow | |||||||
| Net Issuance of Common Stock |
(272)
|
(312)
|
(40)
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
(70)
|
(1)
|
(19)
|
(13)
|
125
|
94
|
|
| Cash Paid for Dividends |
(76)
|
(83)
|
(83)
|
0
|
(115)
|
(237)
|
|
| Other |
(19)
|
(8)
|
(11)
|
6
|
0
|
0
|
|
| Cash from Financing Activities |
(437)
N/A
|
(404)
+8%
|
(153)
+62%
|
(7)
+96%
|
10
N/A
|
(142)
N/A
|
|
| Change in Cash | |||||||
| Net Change in Cash |
31
N/A
|
(208)
N/A
|
16
N/A
|
(8)
N/A
|
(49)
-536%
|
(2)
+96%
|
|
| Free Cash Flow | |||||||
| Free Cash Flow |
(99)
N/A
|
184
N/A
|
713
+287%
|
317
-56%
|
160
-50%
|
440
+175%
|
|
Switch to:
Switch to:
See Also
Discover More
